1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intramuscular Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Drug Molecule
1.2.3 Delivery Devices
1.3 Market by Application
1.3.1 Global Intramuscular Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Autoimmune Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Intramuscular Drug Delivery Market Perspective (2017-2028)
2.2 Intramuscular Drug Delivery Growth Trends by Region
2.2.1 Intramuscular Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Intramuscular Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Intramuscular Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Intramuscular Drug Delivery Market Dynamics
2.3.1 Intramuscular Drug Delivery Industry Trends
2.3.2 Intramuscular Drug Delivery Market Drivers
2.3.3 Intramuscular Drug Delivery Market Challenges
2.3.4 Intramuscular Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intramuscular Drug Delivery Players by Revenue
3.1.1 Global Top Intramuscular Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Intramuscular Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intramuscular Drug Delivery Revenue
3.4 Global Intramuscular Drug Delivery Market Concentration Ratio
3.4.1 Global Intramuscular Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intramuscular Drug Delivery Revenue in 2021
3.5 Intramuscular Drug Delivery Key Players Head office and Area Served
3.6 Key Players Intramuscular Drug Delivery Product Solution and Service
3.7 Date of Enter into Intramuscular Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intramuscular Drug Delivery Breakdown Data by Type
4.1 Global Intramuscular Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Intramuscular Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Intramuscular Drug Delivery Breakdown Data by Application
5.1 Global Intramuscular Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Intramuscular Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Intramuscular Drug Delivery Market Size (2017-2028)
6.2 North America Intramuscular Drug Delivery Market Size by Country (2017-2022)
6.3 North America Intramuscular Drug Delivery Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Intramuscular Drug Delivery Market Size (2017-2028)
7.2 Europe Intramuscular Drug Delivery Market Size by Country (2017-2022)
7.3 Europe Intramuscular Drug Delivery Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intramuscular Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Intramuscular Drug Delivery Market Size by Country (2017-2022)
8.3 Asia-Pacific Intramuscular Drug Delivery Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Intramuscular Drug Delivery Market Size (2017-2028)
9.2 Latin America Intramuscular Drug Delivery Market Size by Country (2017-2022)
9.3 Latin America Intramuscular Drug Delivery Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intramuscular Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2017-2022)
10.3 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Antares Pharma
11.1.1 Antares Pharma Company Detail
11.1.2 Antares Pharma Business Overview
11.1.3 Antares Pharma Intramuscular Drug Delivery Introduction
11.1.4 Antares Pharma Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.1.5 Antares Pharma Recent Development
11.2 Eli Lily
11.2.1 Eli Lily Company Detail
11.2.2 Eli Lily Business Overview
11.2.3 Eli Lily Intramuscular Drug Delivery Introduction
11.2.4 Eli Lily Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.2.5 Eli Lily Recent Development
11.3 Galaxo
11.3.1 Galaxo Company Detail
11.3.2 Galaxo Business Overview
11.3.3 Galaxo Intramuscular Drug Delivery Introduction
11.3.4 Galaxo Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.3.5 Galaxo Recent Development
11.4 HMD pharmaceuticals
11.4.1 HMD pharmaceuticals Company Detail
11.4.2 HMD pharmaceuticals Business Overview
11.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Introduction
11.4.4 HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.4.5 HMD pharmaceuticals Recent Development
11.5 Inovio Pharmaceuticals
11.5.1 Inovio Pharmaceuticals Company Detail
11.5.2 Inovio Pharmaceuticals Business Overview
11.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Introduction
11.5.4 Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.5.5 Inovio Pharmaceuticals Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Intramuscular Drug Delivery Introduction
11.6.4 Merck Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Intramuscular Drug Delivery Introduction
11.7.4 Novartis Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.7.5 Novartis Recent Development
11.8 Pacira Pharmaceuticals
11.8.1 Pacira Pharmaceuticals Company Detail
11.8.2 Pacira Pharmaceuticals Business Overview
11.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Introduction
11.8.4 Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.8.5 Pacira Pharmaceuticals Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Intramuscular Drug Delivery Introduction
11.9.4 Pfizer Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.9.5 Pfizer Recent Development
11.10 Pharmajet
11.10.1 Pharmajet Company Detail
11.10.2 Pharmajet Business Overview
11.10.3 Pharmajet Intramuscular Drug Delivery Introduction
11.10.4 Pharmajet Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.10.5 Pharmajet Recent Development
11.11 Teva Pharmaceutical
11.11.1 Teva Pharmaceutical Company Detail
11.11.2 Teva Pharmaceutical Business Overview
11.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Introduction
11.11.4 Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2017-2022)
11.11.5 Teva Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
